| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Other (expense) income, net | - | - | - | -1 |
| Other income (expense), net | 14 | 10 | 11 | - |
| Net loss | -1,700 | -1,823 | -1,659 | -1,860 |
| Foreign currency translation adjustments | -2 | -1 | - | - |
| Net income (loss) available to common stockholders, basic | - | - | - | -1,860 |
| Comprehensive loss | -1,702 | -1,824 | -1,659 | - |
| Diluted eps | - | - | - | -0.12 |
| Diluted average shares | - | - | - | 15,017,591 |
| Basic and diluted net loss per share (in dollars per share) | -0.1 | -0.11 | -0.1 | -0.12 |
| Weighted average common shares outstanding, basic and diluted (in shares) | 17,033,109 | 15,918,979 | 15,918,979 | 15,017,591 |
Harvard Apparatus Regenerative Technology, Inc. (HRGN)
Harvard Apparatus Regenerative Technology, Inc. (HRGN)